Stockscreener 앱 받기
7.95
4.10%
-0.34
시간 외 거래:
7.94
-0.010
-0.13%
전일 마감가:
$8.29
열려 있는:
$8.4
하루 거래량:
104.56K
Relative Volume:
0.20
시가총액:
$28.77M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+9.20%
1개월 성능:
-11.96%
6개월 성능:
-11.37%
1년 성능:
+0.00%
1일 변동 폭
$7.88
$8.6099
1주일 범위
$6.855
$8.6099
52주 변동 폭
$4.06
$19.44
Traws Pharma Inc Stock (TRAW) Company Profile
명칭
Traws Pharma Inc
전화
267-759-3680
주소
12 PENNS TRAIL, NEWTOWN
TRAW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRAW
Traws Pharma Inc
|
7.95 | 28.77M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-01 | 개시 | Ladenburg Thalmann | Buy |
| 2021-05-18 | 개시 | Guggenheim | Buy |
| 2018-03-01 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-17 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2017-10-09 | 개시 | H.C. Wainwright | Buy |
| 2017-04-27 | 개시 | Laidlaw | Buy |
| 2015-07-01 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2015-05-05 | 개시 | H.C. Wainwright | Buy |
모두보기
Traws Pharma Inc 주식(TRAW)의 최신 뉴스
Traws Pharma Names Nora Brennan Interim CFO -February 07, 2025 at 04:43 pm EST - Marketscreener.com
Orbimed Advisors LLC Expands Stake in Traws Pharma Inc - GuruFocus.com
Traws Pharma Advances Bird Flu Treatment with Successful Phase I Trial - MSN
Traws Pharma completes Phase I trials of H5N1 bird flu treatment drug - Yahoo Finance
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu - Marketscreener.com
Traws Pharma's Bird Flu Drug Shows Promise in Phase I Safety Trial, Targets H5N1 Prevention - StockTitan
Traws Pharma, Expert Systems: Breakthrough in H5N1Bird Flu antiviral program - MSN
Traws Pharma Shares Surge 57% in After-Hours Trading Following Antiviral Trial Update - Yahoo Finance
Traws Pharma (TRAW) Stock Skyrockets In After-Hour Trading - Stocks Telegraph
Traws Pharma Shares Surge 57% in After-Hours Trading Following A - GuruFocus.com
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program - The Malaysian Reserve
Traws stock rallies 24% on avian flu drug update - MSN
Expert Systems And Traws Pharma Report Breakthrough In H5n1bird Flu Antiviral Program - MENAFN.COM
PERCEPTIVE ADVISORS LLC Acquires Significant Stake in Traws Phar - GuruFocus.com
Traws Pharma Secures $72.6 Million for Bird Flu Treatment Development - MSN
SEC Form 424B4 filed by Traws Pharma Inc. - Quantisnow
Traws Pharma secures up to $72.6 million in funding By Investing.com - Investing.com Canada
Traws stock plunges 43% on financing update - MSN
Traws Pharma, Inc. announced that it expects to receive $72.6 million in funding - Marketscreener.com
Is Traws Pharma Inc (NASDAQ: TRAW) Doomed From The Get-Go? - Stocks Register
Bucks County firm's shares plunge on capital raise plan - The Business Journals
Traws stock plunges 43% on financing update (TRAW:NASDAQ) - Seeking Alpha
Crude Oil Gains 1%; Chicago PMI Falls In December - Benzinga
Stock market news: Abpro Holdings -52.75%, Traws Pharma -42.47% among biggest losers during mid day trading - Business Upturn
Dismal Market Sentiment Pushes VIX Higher - Schaeffers Research
Traws Pharma Secures $72.6 Million in Financing to Advance Bird Flu Treatment Development - Tandav Media
Stock market today: Abpro Holdings -42.09%, Traws Pharma -39.26% among biggest losers in early trading - Business Upturn
Stock market news: Intrusion surged by 123.33% while Snow Lake Resources plunged by 21.88% in early trading - Business Upturn
Traws Pharma secures up to $72.6 million in funding - Investing.com India
Traws Pharma announces $72.6M financing - TipRanks
Traws Pharma Secures $72.6M Financing for Bird Flu Drug Development from Leading Healthcare Investors - StockTitan
Single Peoples' Personalities Differ from Partnered Peoples' - 69News WFMZ-TV
Traws Pharma stock soars 200% on encouraging bird flu drug data - MSN
Traws Pharma soars as it advances H5N1 bird flu treatment - The Pharma Letter
Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
Traws Pharma, Inc. Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu - Marketscreener.com
Nasdaq Surges Over 100 Points, US Durable Goods Orders Decline In November - Benzinga
Traws Pharma (TRAW) Shares Jump On Strong Trial Results - Stocks Telegraph
Traws Pharma Stock Rockets On Promising H5N1 Bird Flu Treatment Results - Benzinga
Traws Pharma Stock Hits 6-Month Highs On Bird Flu Treatment Breakthrough, Retail Interest Soars - MSN
Stock market news: Direct Digital Holdings +405.45%, Reliance Global Group +214.17% among top gainers during mid day trading - Business Upturn
Stock market news: Direct Digital Holdings up by 363.64% while iLearningEngines down by 70.88% during mid day trading - Business Upturn
Key pre-market developments in biotech & aerospace - RagingBull
Stock market today: Traws Pharma +231.47%, Rumble +59.02% among top gainers in early trading - Business Upturn
US Stocks Mixed, Dow Tumbles 150 Points - Benzinga
Stock market today: iLearningEngines plunges by 60.44% while Reliance Global Group surged by 231.67% in early trading session - Business Upturn
Traws Pharma Shares Surge 83% on Development of Bird Flu Treatment - MarketWatch
Traws Pharma advances bird flu treatment candidate - Investing.com
Traws Pharma's Bird Flu Drug Shows Breakthrough Results in Phase 1 Trial, Achieves 23-Day Protection - StockTitan
The Most Therapeutic Kind of Me-Time - 69News WFMZ-TV
Traws Pharma announces board member departure By Investing.com - Investing.com Australia
Traws Pharma Inc (TRAW) 재무 분석
Traws Pharma Inc (TRAW)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.09%
자본화:
|
볼륨(24시간):